Close Menu

Quidel

Quidel this week provided an update on its budding molecular diagnostics business, noting that it saw "significant progress" in each of its three MDx initiatives.

Quidel in December received 510(k) clearance from the US Food and Drug Administration for two molecular diagnostic tests, the company's first two molecular tests to receive such approval.

This article has been updated from a previous version to correct the spelling of Quidel's AmpliVue technology.
By Ben Butkus

Quidel said this week that John Radak will be stepping down from his role as CFO, and that Randy Steward will be taking his place effective Oct. 31.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Life Technologies will distribute and sell Quidel's molecular diagnostic assays in Europe under an agreement announced today.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.